Subscribe
Logo smallSearch
banner

GIF denies reports of quality defects in Janssen's XD955 vaccine series

MedExpress Team

Medexpress

Published Oct. 10, 2023 11:05

GIF denies reports of quality defects in Janssen's XD955 vaccine series - Header image
Źródło: GIF
No quality defect has ever been found with regard to Janssen's XDD955 series of Covid-19 vaccine. This must be made clear, giving the lie to any reports in the public space that Polish patients received a defective vaccine.

Covid-19 vaccines are registered in a central procedure. This means that the European Medicines Agency (EMA) has taken over supervision of their safety. In turn, inspections at the vaccine manufacturer are carried out by the agency from the country where the production facility is located.

The EMA has exchanged information on the safety of these medicinal products with the drug agencies of EU member states throughout the SARS CoV-2 virus pandemic. One of the EMA's communication platforms with national drug agencies is the Rapid Alert System. We explain how the drug agencies communicated through this system in the case of Janssen's vaccine with batch number XD955.

April 2021

In April 2021, the FDA (U.S...

Content locked

To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].

If you already have an account, please log in

Szukaj nowych pracowników

Dodaj ogłoszenie już za 4 zł dziennie*.

* 4 zł netto dziennie. Minimalny okres ekspozycji ogłoszenia to 30 dni.

Read also